Correction to: Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study

Benzer Materyaller

• Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study
  Yazar:: Naganuma, Makoto, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis
  Yazar:: Naganuma, Makoto, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam
  Yazar:: Naganuma, Makoto, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trials
  Yazar:: Hibi, Toshifumi, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis
  Yazar:: Rubin, David T., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)